These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21519948)

  • 1. Change of formulation decreases venous irritation in breast cancer patients receiving epirubicin.
    Nagata K; Egashira N; Yamada T; Watanabe H; Yamauchi Y; Oishi R
    Support Care Cancer; 2012 May; 20(5):951-5. PubMed ID: 21519948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Improvement of epirubicin-induced phlebitis to switch from liquid preparation to lyophilized formulation].
    Suga Y; Kumazaki M; Nishigami J; Takeda K; Kawagishi A; Ishizaki J; Inokuchi M; Miyamoto K; Arai K
    Gan To Kagaku Ryoho; 2009 Jan; 36(1):93-6. PubMed ID: 19151570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decrease in the vinorelbine-induced venous irritation by pharmaceutical intervention.
    Yamada T; Egashira N; Watanabe H; Nagata K; Yano T; Nonaka T; Oishi R
    Support Care Cancer; 2012 Jul; 20(7):1549-53. PubMed ID: 21805382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epirubicin chemotherapy in women with breast cancer: Alternating arms for intravenous administration to reduce chemical phlebitis.
    Roberts R; Hanna L; Borley A; Dolan G; Williams EM
    Eur J Cancer Care (Engl); 2019 Sep; 28(5):e13114. PubMed ID: 31148328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Promising new injection method to prevent angialgia/phlebitis from epirubicin hydrochloride therapy for breast cancer].
    Ono C; Yamagami M; Kamatani R; Yamamoto M; Mukouyama T; Sugimoto M; Suzuki T; Kamo N; Seki N; Eguchi K; Ikeda T
    Gan To Kagaku Ryoho; 2012 May; 39(5):777-81. PubMed ID: 22584330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of venous pain and phlebitis caused by epirubicin hydrochloride.
    Sugimoto M; Matsui M; Harada M; Yamauchi Y; Moriyama N; Andou K; Yamamoto M; Yamaoka H; Ono C; Ishikawa M; Kamo N; Ikeda T; Yamaoka K
    Gan To Kagaku Ryoho; 2009 Jun; 36(6):969-74. PubMed ID: 19542717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy induced phlebitis experienced by women with breast cancer following administration of epirubicin using a volumetric infusion pump: an observational study.
    Williams N; Williams EM; Roberts R
    Eur J Oncol Nurs; 2023 Jun; 64():102322. PubMed ID: 37141665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological study and pharmaceutical intervention to reduce intravenous injection-induced vascular injury].
    Yamada T
    Yakugaku Zasshi; 2015; 135(3):465-72. PubMed ID: 25759054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epirubicin as adjuvant therapy for breast cancer.
    Suh C
    Cancer Pract; 2001; 9(2):104-6. PubMed ID: 11879287
    [No Abstract]   [Full Text] [Related]  

  • 10. A phase II trial of high dose epirubicin in patients with advanced breast carcinoma.
    Miller DK; Munshi N; Loesch D; Einhorn LE; Sledge GW
    Cancer; 2000 Jan; 88(2):375-80. PubMed ID: 10640971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients.
    Ryberg M; Nielsen D; Cortese G; Nielsen G; Skovsgaard T; Andersen PK
    J Natl Cancer Inst; 2008 Aug; 100(15):1058-67. PubMed ID: 18664656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer. The Provincial Systemic Treatment Disease Site Group.
    Seymour L; Bramwell V; Moran LA
    Cancer Prev Control; 1999 Apr; 3(2):145-59. PubMed ID: 10474762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous irritation related to intravenous administration of phenytoin versus fosphenytoin.
    Jamerson BD; Dukes GE; Brouwer KL; Donn KH; Messenheimer JA; Powell JR
    Pharmacotherapy; 1994; 14(1):47-52. PubMed ID: 8159601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Risk Factors for Oxaliplatin-Induced Phlebitis and Venous Pain, and Evaluation of the Preventive Effect of Preheating with a Hot Compress for Administration of Oxaliplatin].
    Nakauchi K; Kawazoe H; Miyajima R; Waizumi C; Rokkaku Y; Tsuneoka K; Higuchi N; Fujiwara M; Kojima Y; Yakushijin Y
    Gan To Kagaku Ryoho; 2015 Nov; 42(11):1397-400. PubMed ID: 26602398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel by 72-hour continuous infusion followed by bolus intravenous ifosfamide or epirubicin: results of two phase I studies.
    Miglietta L; Marenghi C; Nizzo R; Foglia G; Ragni N; Boccardo F
    Oncology; 2001; 60(2):116-22. PubMed ID: 11244325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Images in clinical medicine. Extravasation of epirubicin.
    Vano-Galvan S; Jaen P
    N Engl J Med; 2009 May; 360(20):2117. PubMed ID: 19439746
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessing and managing venous irritation associated with vinorelbine tartrate (Navelbine).
    Rittenberg CN; Gralla RJ; Rehmeyer TA
    Oncol Nurs Forum; 1995 May; 22(4):707-10. PubMed ID: 7675673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of clinical study with epirubicin hydrochloride injectable solution for superficial bladder cancer. IMI28 Injectable Solution Study Group for Superficial Bladder Cancer].
    Kotake T; Koyanagi T; Akaza H; Shimazaki J; Ito H; Hosaka M; Okajima E; Saito Y; Miyanaga N; Kuroda M; Hirao Y
    Gan To Kagaku Ryoho; 1998 Jul; 25(8):1189-95. PubMed ID: 9679582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epirubicin cardiotoxicity: an analysis of 469 patients with metastatic breast cancer.
    Ryberg M; Nielsen D; Skovsgaard T; Hansen J; Jensen BV; Dombernowsky P
    J Clin Oncol; 1998 Nov; 16(11):3502-8. PubMed ID: 9817267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of manic episode during treatment with 5-fluorouracil, epirubicin and cyclophosphamide for breast cancer.
    Pacchiarotti I; Mazzarini L; Pellegrini P; Venturelli V; Sani G; Sánchez-Moreno J; Mancinelli I; Tatarelli R; Kotzalidis GD; Girardi P
    Gen Hosp Psychiatry; 2007; 29(5):461-3. PubMed ID: 17888816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.